Description
Cys-mcMMAD is a agent-linker conjugate for ADC. MMAD is a potent tubulin inhibitor.–20°C (Powder, protect from light)-Applications-Neuroscience-Neuromodulation-Formula-C54H84N8O11S2-Citation–References-[1]Antibody-drug conjugates Patent: WO 2013068874 A1-CASNumber–MolecularWeight-1085.42-Compound Purity-98.77-SMILES-CC[C@H](C)[C@@H]([C@@H](CC(N1[C@@H](CCC1)[C@@H]([C@@H](C)C(N[C@H](C2=NC=CS2)CC3=CC=CC=C3)=O)OC)=O)OC)N(C([C@H](C(C)C)NC([C@H](C(C)C)N(C(CCCCCN4C(CC(SC[C@@H](C(O)=O)N)C4=O)=O)=O)C)=O)=O)C-Research_Area-Cancer-Solubility-DMSO : 200 mg/mL (ultrasonic)-Target-Drug-Linker Conjugates for ADC;Microtubule/Tubulin-Isoform-Auristatin-Pathway-Antibody-drug Conjugate/ADC Related;Cell Cycle/DNA Damage;Cytoskeleton-MCE Product type-ADC Related
